Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.

Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics

de la Torre, Jack C · 2004 · The Lancet Neurology

Abstract

The cause of Alzheimer's disease (AD) is unknown. This gap in knowledge has created a stumbling block in the search for a genuinely effective treatment or cure for this dementia. This article summarises the arguments for a causal role for either amyloid deposition or cerebrovascular pathology as the primary trigger in the development of non-genetic AD. A bare-bones survey of the published research reveals no compelling evidence that amyloid deposition is neurotoxic in human beings or that it results in neurodegenerative changes involving synaptic, metabolic, or neuronal loss in human or transgenic-mouse brains. By contrast, the data supporting AD as a primary vascular disorder are more convincing. Findings suggesting a vascular cause of AD come from epidemiological, neuroimaging, pathological, pharmacotherapeutic, and clinical studies. The consensus of these studies indicates that chronic brain hypoperfusion is linked to AD risk factors, AD preclinical detection and pharmacotherapeutic action of AD symptoms.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(04)00683-0

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 110 references

Research works printed but not linked: 5

  1. Davis, 1997, The 'amyloid' cascade hypothesis of AD: decoy or real McCoy?, Trends Neurosci, 20, 558
  2. DeCarli, 1992, Post-mortem regional neurofibrillary tangle densities, but not senile plaque densities are related to regional cerebral metabolic rates for glucose during life in Alzheimer disease patients, Neurodegeneration, 1, 11
  3. Steinberg, 2002, Companies halt first Alzheimer vaccine trial, Scientist, 16, 22
  4. 1997, Cerebrovascular pathology in Alzheimer's disease: proceedings of a conference, East Rutherford, New Jersey, Nov 12–15, 1996, Ann NY Acad Sci, 826, 1
  5. de la Torre, 1997, Hemodynamic consequences of deformed microvessels in the brain in Alzheimer's disease, Ann NY Acad Sci, 826, 75, 10.1111/j.1749-6632.1997.tb48462.x · DOI

Cited by

See all 834

Metadata

Authors
de la Torre, J. C.
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2004-03
Volume
3
Issue
3
Pages
184-190
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2042902316
Cited by
834
References
110
Citations by year
2026: 10 · 2025: 19 · 2024: 19 · 2023: 22 · 2022: 22 · 2021: 31 · 2020: 47 · 2019: 36 · 2018: 32 · 2017: 39 · 2016: 63 · 2015: 32 · 2014: 46 · 2013: 36 · 2012: 60
FWCI
4.25
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet Neurology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
Alzheimer's disease, neurodegeneration, cerebrovascular pathology, amyloid deposition, neurotoxicity, dementia pathogenesis, vascular hypothesis, preclinical Alzheimer's disease, transgenic mouse model
MeSH terms
Alzheimer Disease, Animals, Brain, Cerebral Arteries, Cerebrovascular Disorders, Diagnostic Imaging, Humans, Risk Factors, Neurofibrillary Tangles, Neurodegenerative Diseases, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. https://app.cochat.ai/papers/10.1016/s1474-4422(04)00683-0
The paper
de la Torre, J. C. (2004). Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(04)00683-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.